Effectiveness of femoro-femoral crossover bypass in patients with critical limb ischemia: a retrospective clinical analysis

R.O. Makkamov, Almas Saduakas, M.A. Zhakubayev, А.Ж. Маткеримов, N.N. Yerkinbayev, T N Demeuov, А С Шамшиев

2026

Closed access Metadata (CSL-JSON)
DOI 10.33029/1027-6661-2026-32-2-117-122
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

AIM: To evaluate the effectiveness of femoro-femoral crossover bypass in high-risk patients with unilateral aorto-iliac occlusive disease. MATERIAL AND METHODS: A retrospective analysis was conducted on 26 patients (22 men, 4 women; mean age 67.8±7.4 years) who underwent femoro-femoral crossover bypass using a ring-reinforced PTFE graft at the National Scientific Center of Surgery named after A.N. Syzganovbetween 2017 and 2025. Graft patency, postoperative complications, mortality, and limb salvage were assessed during early and long-term follow-up. RESULTS: All operations were technically successful with restoration of distal blood flow in 100% of cases. Postoperative complications occurred in 2 patients (7.6%): one late graft infection and one in-hospital death (3.8%). The mean hospital stay was 14±5 days. At five-year follow-up (available in 9 patients), graft patency remained 100%, with complete limb salvage and no major reinterventions. CONCLUSION: Femoro-femoral crossover bypass is a safe and reliable revascularization method for patients with aorto-iliac occlusive disease who are unsuitable for direct aortic reconstruction. The procedure provides excellent long-term patency, full limb salvage, and minimal morbidity and mortality.